April 29, 2004 — The U.S. Food and Drug Administration (FDA) has approved an apomorphine injection for Parkinson's disease, a pediatric indication for fluticasone propionate and salmeterol 100/50 µg ...

TORONTO, CANADA--(Marketwired - Jan 13, 2014) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH) (CYNAF), a specialty pharmaceutical company, today announced positive top line data from its recently ...

Apomorphine sublingual film (Kynmobi, Sunovion Pharmaceuticals) was efficacious and generally safe and well tolerated for the on-demand treatment of OFF episodes in Parkinson's disease, long-term ...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...

Apomorphine, a 150-year-old drug for Parkinson’s disease is found to lower ‘off’ time for people at an advanced stage of the disease. Apomorphine has been in use for many years, but its significance ...

AUGUSTA, Ga. (Feb. 14, 2017) - Constant infusion of a drug now used intermittently to "rescue" patients with Parkinson's from bouts of immobility may also help avoid these debilitating symptoms and ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) on March ...

Constant infusion of a drug now used intermittently to "rescue" patients with Parkinson's from bouts of immobility may also help avoid these debilitating symptoms and smooth out their movement ...

In a first of sorts, drugmaker Rusan Pharma is unveiling apomorphine injections in the country, a product that helps tackle fluctuating motor functions in people with Parkinson’s disease. Parkinson’s ...

Apomorphine, which is said to be an effective drug to treat Parkinson BENGALURU: Fifteen years after being in use in the West, a drug with proven efficacy against Parkinson’s disease is set to enter ...

Results Support Expected 505(b)2 Path to New Drug Application (NDA) in the United States TORONTO, CANADA, Jan 13, 2014 (Marketwired via COMTEX) -- Cynapsus Therapeutics Inc. CA:CTH +3.49% (otcqx:CYNAF ...